Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression
Open Access
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (17) , 6434-6448
Abstract
No abstract availableKeywords
Funding Information
- HHS | National Institutes of Health (NIH) (R01CA172495)
- U.S. Department of Defense (DOD) (W81XWH-15–1-0507)
This publication has 59 references indexed in Scilit:
- N-Terminal Region of the Catalytic Domain of Human N-Myristoyltransferase 1 Acts as an Inhibitory ModulePLOS ONE, 2015
- Global profiling of co- and post-translationally N-myristoylated proteomes in human cellsNature Communications, 2014
- Prostate cancer cell–stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastasesScience Translational Medicine, 2014
- Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical PerspectivesCancer Discovery, 2013
- FGFR2 alterations in endometrial carcinomaLaboratory Investigation, 2011
- Differential transformation capacity of Src family kinases during the initiation of prostate cancerProceedings of the National Academy of Sciences, 2011
- Design, Structure−Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase InhibitorsJournal of Medicinal Chemistry, 2008
- The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenograftsThe Prostate, 2003
- In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchymeProceedings of the National Academy of Sciences, 2003
- Reduced Activation of RAF-1 and MAP Kinase by a Fibroblast Growth Factor Receptor Mutant Deficient in Stimulation of Phosphatidylinositol HydrolysisJournal of Biological Chemistry, 1995